2003 approvals: a year of innovation and upward trends (original) (raw)

Abstract

Although the number of new molecular entities approved in 2003 was only marginally higher than in 2002, approvals for innovative drugs were encouraging.

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

• Purchase on SpringerLink
• Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

• Log in
• Learn about institutional subscriptions
• Read our FAQs
• Contact customer support

Supplementary information

Rights and permissions

About this article

Cite this article

Frantz, S. 2003 approvals: a year of innovation and upward trends.Nat Rev Drug Discov 3, 103–105 (2004). https://doi.org/10.1038/nrd1327

Download citation

• Issue Date: 01 February 2004
• DOI: https://doi.org/10.1038/nrd1327

This article is cited by

• Can the pharmaceutical industry reduce attrition rates?

  • Ismail Kola
  • John Landis
    Nature Reviews Drug Discovery (2004)